↓ Skip to main content

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
<p>Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report</p>
Published in
Therapeutics and Clinical Risk Management, February 2019
DOI 10.2147/tcrm.s186855
Pubmed ID
Authors

Masashi Uehara, Yukio Nakamura, Jun Takahashi, Takako Suzuki, Mari Iijima, Yuko Arakawa, Koichi Ida, Tomoki Kosho, Hiroyuki Kato

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 20%
Student > Bachelor 2 20%
Professor 1 10%
Other 1 10%
Researcher 1 10%
Other 0 0%
Unknown 3 30%
Readers by discipline Count As %
Medicine and Dentistry 3 30%
Nursing and Health Professions 1 10%
Veterinary Science and Veterinary Medicine 1 10%
Unknown 5 50%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2021.
All research outputs
#11,513,443
of 17,726,748 outputs
Outputs from Therapeutics and Clinical Risk Management
#758
of 1,107 outputs
Outputs of similar age
#202,717
of 336,457 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 1 outputs
Altmetric has tracked 17,726,748 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,107 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,457 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them